Investors in Array Technologies Inc (Symbol: ARRY) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDs Array BioPharma (NASDAQ: ARRY) today announced ...
Array BioPharma Inc. (NASDAQ: ARRY) announced the presentation of two abstracts detailing positive data for its novel, small molecule ErbB family inhibitor, ARRY-543. The abstracts, which were ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
ARRY reported solid Q2 FY23 results, with a 21% rise in revenue and significant improvement in gross margins. The stock price of ARRY has shown strength and potential for an uptrend after breaking out ...